Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SIGA Technologies Inc. - Common Stock (NQ:SIGA)

4.485 -0.065 (-1.43%)
Streaming Delayed Price Updated: 10:25 AM EDT, May 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about SIGA Technologies Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Siga Technologies Q1 Earnings Call Highlights ↗
Siga Technologies (NASDAQ:SIGA) reported a first-quarter loss as product deliveries remained minimal, but management said it expects a pickup in the second quarter tied to an international order and... 
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
SIGA (SIGA) Q1 2026 Earnings Call Transcript ↗
SIGA (SIGA) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Supply Chain
News headline image
Why Are Siga Technologies Shares Trading Higher? ↗
SIGA Technologies Inc. (NASDAQ: SIGA) shares are trading higher Friday after the company declared a special cash dividend of $0.60 per share. 
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
NIH Trial Finds Tecovirimat Ineffective As Monotherapy For Mpox ↗
SIGA Technologies’ (NASDAQ:SIGA) antiviral drug tecovirimat, when used without other treatments, did not reduce the time for clade ... 
Via Benzinga
News headline image
SIGA (SIGA) Q2 Revenue Soars 272% ↗
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
3 Healthcare Stocks Paying the Highest Dividends of 2025 ↗
Income investors seeking juicy dividends should check out these healthcare stocks. 
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Stocks Upping Dividends & 1 With A 10% Special Dividend Yield
Via MarketBeat
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
The regular session of the US market on Monday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
News headline image
Earnings Scheduled For March 11, 2025 ↗
 
Via Benzinga
News headline image
Japan Approves SIGA Technologies Antiviral As First For Smallpox, Mpox ↗
Japan approves SIGA's TEPOXX for smallpox, mpox, and cowpox, expanding antiviral availability for orthopoxviruses with proven safety and efficacy. 
Via Benzinga
News headline image
Arm Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket ↗
Shares of Rumble Inc. 
Via Benzinga
News headline image
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped' ↗
To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan. 
Via Benzinga
News headline image
Government Contract Win May Improve Investor Sentiment For SIGA Tech After Disappointing Trial Data: Analyst ↗
SIGA Technologies secures a $9 million DoD contract for TPOXX, boosting total outstanding orders to $154 million. Recent BARDA and DoD wins reinforce growth despite challenges in a key mpox trial. 
Via Benzinga
News headline image
Immunome Stock Sees RS Rating Jump To 91 ↗
Immunome stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 88 to 91. 
Via Investor's Business Daily
News headline image
PTC Therapeutics Stock Earns RS Rating Upgrade To 83 ↗
The Relative Strength (RS) Rating for PTC Therapeutics stock climbed into a new percentile Monday, with a rise from 80 to 83. 
Via Investor's Business Daily
News headline image
3 Promising Vaccine Stocks To Watch In The Event Of A Mpox Surge ↗
Mpox rerun is making these stocks soar. But a non-vaccine approach could yield greater gains. 
Via Talk Markets
News headline image
Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening ↗
Increased screening for deadly new version of mpox is seen in Europe and China. More imported cases are expected. New vaccines are being developed. 
Via Benzinga
News headline image
Stock Of The Day: Bull Trap Snares SIGA Technologies On Heels Of Mpox Study ↗
Shares of SIGA Technologies (SIGA) had a 'bull trap' on Wednesday. There may be another one today. This can mean the stock is headed lower. 
Via Benzinga
News headline image
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Crude Oil Gains Over 1%; Alibaba Posts Weak Revenue ↗
 
Via Benzinga
News headline image
Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On? ↗
Several healthcare stocks associated with mpox are seeing increased attention Thursday after the World Health Organization declared a public health emergency in response to an mpox outbreak in Africa. 
Via Benzinga
News headline image
Russell 2000 Set For Strongest Session In A Month As US Economy Defies Recession Fears: Small Cap Movers On Thursday ↗
Russell 2000 ETF (ARCA: IWM) up 2.7%, its strongest session in a month, driven by positive economic data & increased consumer spending, boosting confidence in US economy. 
Via Benzinga
Topics ETFs Economy
News headline image
Nasdaq Jumps Over 2%; Walmart Earnings Top Views ↗
 
Via Benzinga
News headline image
Dow Surges Over 500 Points; US Retail Sales Rise In July ↗
 
Via Benzinga
Topics Stocks
News headline image
In NIH-Cosponsored Monkeypox Virus Study In Congo, SIGA Technologies' Antiviral Tecovirimat Did Not Improve Lesion Resolution, Stock Tanks ↗
"NIH's NIAID reveals results from the PALM 007 trial of SIGA Technologies' Tpoxx for monkeypox (mpox) treatment. The study missed its primary endpoint but showed potential benefits in early and severe... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.